Bonomi M, Rochira V, Pasquali D, Balercia G, Jannini E A, Ferlin A
Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Division of Endocrine and Metabolic Diseases & Laboratory of Endocrine and Metabolic Research, IRCCS Istituto Auxologico Italiano, Milan, Italy.
J Endocrinol Invest. 2017 Feb;40(2):123-134. doi: 10.1007/s40618-016-0541-6. Epub 2016 Sep 19.
Klinefelter Syndrome (KS) is characterized by an extreme heterogeneity in its clinical and genetic presentation. The relationship between clinical phenotype and genetic background has been partially disclosed; nevertheless, physicians are aware that several aspects concerning this issue are far to be fully understood. By improving our knowledge on the role of some genetic aspects as well as on the KS, patients' interindividual differences in terms of health status will result in a better management of this chromosomal disease. The aim of this review is to provide an update on both genetic and clinical phenotype and their interrelationships.
克兰费尔特综合征(KS)在临床和基因表现上具有高度异质性。临床表型与基因背景之间的关系已部分揭示;然而,医生们意识到关于这个问题的几个方面远未得到充分理解。通过增进我们对一些基因方面作用以及对KS的了解,患者在健康状况方面的个体差异将有助于更好地管理这种染色体疾病。本综述的目的是提供关于基因和临床表型及其相互关系的最新信息。